Clinical trial
TBE Antibody Persistence and Booster Vaccination Study in Children and…
NCT00161967 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00161967 |
|---|---|
| Title | TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) |
| Official title | Open-label Follow-up Study to Investigate the Seropersistence of TBE Antibodies and the Booster Response to a Tick-borne Encephalitis Vaccine in Children and Adolescents Aged 3 - 18 Years |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Encephalitis, Tick-Borne |
| Intervention type | Biological |
| Interventions | Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) |
| Enrollment | 375 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Sep 13, 2005 |
| Last update posted | May 21, 2015 |
| Countries | Austria, Germany, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: